Adrienne Anderson
Medical · Atlanta, GANPI 1841738044
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 954 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 54 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 954 payments — averaging $26.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Xeris Pharmaceuticals, Inc.$2K
- Tandem Diabetes Care, Inc.$2K
- Novo Nordisk$2K
- Corcept Therapeutics$2K
- Insulet Corporation$1K
- plus $12K from 48 others
What the payments were for
- Travel & lodging$2,2709%
- Food & beverage$22,64591%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$2,043
- MINIMED 780G$1,803
- iLet Bionic Pancreas$960
- GVOKE PFS$474
- Korlym$367
- DEXCOM G6 TRANSMITTER$359
- Omnipod$355
- RECORLEV$234
- GVOKE HYPOPEN$216
- UNITY DIABETES MANAGEMENT SYSTEM$152
- TEPEZZA$145
- Minimed 770G System$129
- Saxenda$122
- Yorvipath$122
- Wegovy$121
- DEXCOM G7 GSS (161)$121
- Prolia$120
- MOUNJARO$115
How this compares
$24,926 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 184 | $301,012 |
| KorlymMifepristone | 20 | $233,970 |
| MounjaroTirzepatide | 132 | $158,698 |
| RybelsusSemaglutide | 51 | $100,760 |
| TrulicityDulaglutide | 52 | $86,420 |
| JardianceEmpagliflozin | 49 | $60,882 |
| FarxigaDapagliflozin Propanediol | 31 | $41,274 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 39 | $40,831 |
| Repatha SureclickEvolocumab | 33 | $26,364 |
| JanuviaSitagliptin Phosphate | 24 | $24,858 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 24 | $23,743 |
| Tresiba Flextouch U-100Insulin Degludec | 40 | $23,167 |
| GenotropinSomatropin | 15 | $15,660 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $11,651 |
| Gvoke Hypopen 2-PackGlucagon | 14 | $9,385 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $2,325 | $407,052257 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,145 | $252,544210 claims |
| Corcept TherapeuticsKorlym | $1,649 | $233,97020 claims |
| Boehringer IngelheimJardiance | $558 | $60,88249 claims |
| AstraZenecaFarxiga | $459 | $41,27431 claims |
| MerckJanuvia | $138 | $24,85824 claims |
| AbbVieSynthroid, Armour Thyroid | $297 | $5,70648 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $537 | $1,260141 claims |
| Sanofi-aventis U.S. LLCLantus | $851 | $1,06612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 950 medical providers in Georgia.
Other medical in Atlanta
- Kimberly OrleckAtlanta$727K
- Danna Dennis-CalderAtlanta$87K
- Ferrina ShethAtlanta$49K
- Adriana RuizAtlanta$39K
- Punam PunjaAtlanta$31K
- Jeremiah RobinsonAtlanta$23K
- Steven SchmittAtlanta$15K
- Taylor WeintraubAtlanta$15K
- Margaret SellersAtlanta$11K
- Katherine QuinleyAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.